India vs Sierra Leone: Average cost of tuberculosis treatment multi drug resistant
India
400
in 2024
Sierra Leone
369
in 2024
India rank
87th
Sierra Leone rank
88th
Average cost of tuberculosis treatment multi drug resistant over time
- India
- Sierra Leone
How they compare
India currently reports 400 against 369 in Sierra Leone, a difference of 31.
That makes India's figure about 1.1 times Sierra Leone's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was India ahead.
India ranks 87th and Sierra Leone ranks 88th of 92 countries.
Across the 2 decades both report, India averaged higher in 1 and Sierra Leone in 1.
Head to head by decade
| Decade | India | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,700 | 1,403 | 297 | India |
| 2020s | 476.67 | 1,564 | 1,087 | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment multi drug resistant, India or Sierra Leone?
- India, at 400 against 369 in Sierra Leone as of 2024.
- What is the difference in average cost of tuberculosis treatment multi drug resistant between India and Sierra Leone?
- 31, with India ahead.
- How many years of comparable data are there for India and Sierra Leone?
- 6 years are reported by both, from 2017 to 2024.
- How do India and Sierra Leone rank globally for average cost of tuberculosis treatment multi drug resistant?
- India ranks 87th and Sierra Leone ranks 88th of 92 countries.
- Where does this data come from?
- Our World in Data, published as Average cost of tuberculosis treatment multi drug resistant. Statizoid refreshes it automatically from the source and publishes the full history for both places.